3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
US12054504B2 · kind B2 · utility
0Cited by
25References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2022 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Aug 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to 3-cyclic amine-indole derivatives of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses, and other neurological diseases, disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.